{"id":"https://openalex.org/W2642659480","doi":"https://doi.org/10.1182/blood.v128.22.196.196","title":"The Multiple Myeloma Genome Project: Development of a Molecular Segmentation Strategy for the Clinical Classification of Multiple Myeloma","display_name":"The Multiple Myeloma Genome Project: Development of a Molecular Segmentation Strategy for the Clinical Classification of Multiple Myeloma","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2642659480","doi":"https://doi.org/10.1182/blood.v128.22.196.196","mag":"2642659480"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.196.196","doi":"https://doi.org/10.1182/blood.v128.22.196.196","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.196.196","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042516164","display_name":"Brian A. Walker","orcid":"https://orcid.org/0000-0002-8615-6254","observed_orcids":["https://orcid.org/0000-0002-8615-6254"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian A Walker","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet K. Samur","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002539266","display_name":"Konstantinos Mavrommatis","orcid":"https://orcid.org/0000-0003-4549-385X","observed_orcids":["https://orcid.org/0000-0003-4549-385X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Konstantinos Mavrommatis","raw_affiliation_strings":["Celgene Corporation, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, San Francisco, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090728387","display_name":"Cody Ashby","orcid":"https://orcid.org/0000-0002-9361-0283","observed_orcids":["https://orcid.org/0000-0002-9361-0283"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cody Ashby","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084133067","display_name":"Christopher P. Wardell","orcid":"https://orcid.org/0000-0002-9416-7818","observed_orcids":["https://orcid.org/0000-0002-9416-7818"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher P Wardell","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria Ortiz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Ortiz","raw_affiliation_strings":["Celgene Institute for Translational Research Europe, Celgene Corporation, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Institute for Translational Research Europe, Celgene Corporation, Seville, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023113485","display_name":"Fadi Towfic","orcid":"https://orcid.org/0000-0001-6756-647X","observed_orcids":["https://orcid.org/0000-0001-6756-647X"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fadi Towfic","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Caleb K. Stein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caleb K. Stein","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007618693","display_name":"Michael Bauer","orcid":"https://orcid.org/0000-0003-2498-7295","observed_orcids":["https://orcid.org/0000-0003-2498-7295"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A Bauer","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108778282","display_name":"Michael D. Amatangelo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Amatangelo","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050977500","display_name":"Giovanni Parmigiani","orcid":"https://orcid.org/0000-0002-8783-5961","observed_orcids":["https://orcid.org/0000-0002-8783-5961"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Parmigiani","raw_affiliation_strings":["Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009131337","display_name":"Zhinuan Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhinuan Yu","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081730157","display_name":"Matthew W. B. Trotter","orcid":"https://orcid.org/0000-0003-3702-915X","observed_orcids":["https://orcid.org/0000-0003-3702-915X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Trotter","raw_affiliation_strings":["Celgene Institute for Translational Research Europe, Celgene Corporation, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Institute for Translational Research Europe, Celgene Corporation, Seville, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087620","display_name":"Centre de Recherches en Canc\u00e9rologie de Toulouse","ror":"https://ror.org/003412r28","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210087620","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve Avet-Loiseau","raw_affiliation_strings":["Centre de Recherche en Canc\u00e9rologie de Toulouse Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Toulouse, France","IUC-Oncopole, Unite de Genomique du Myelome, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche en Canc\u00e9rologie de Toulouse Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Toulouse, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087620"]},{"raw_affiliation_string":"IUC-Oncopole, Unite de Genomique du Myelome, Toulouse, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081247376","display_name":"Graham Hunter Jackson","orcid":"https://orcid.org/0000-0003-0756-969X","observed_orcids":["https://orcid.org/0000-0003-0756-969X"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham H Jackson","raw_affiliation_strings":["Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028526208","display_name":"Anjan Thakurta","orcid":"https://orcid.org/0000-0003-0415-1706","observed_orcids":["https://orcid.org/0000-0003-0415-1706"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjan Thakurta","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100632493","display_name":"Gareth John Morgan","orcid":"https://orcid.org/0000-0002-4271-6360","observed_orcids":["https://orcid.org/0000-0002-4271-6360","https://orcid.org/0000-0002-1275-2010","https://orcid.org/0000-0001-7073-2723"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gareth J Morgan","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.3168,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.72082014,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"128","issue":"22","first_page":"196","last_page":"196"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/molecular-classification","display_name":"molecular classification","score":0.8579999804496765},{"id":"https://openalex.org/keywords/chromosomal-translocation","display_name":"chromosomal translocation","score":0.7329999804496765},{"id":"https://openalex.org/keywords/tp53-deletion","display_name":"TP53 deletion","score":0.9789999723434448},{"id":"https://openalex.org/keywords/1q21-amplification","display_name":"1q21 amplification","score":0.953000009059906},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8379999995231628},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.5659999847412109},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.33799999952316284},{"id":"https://openalex.org/keywords/prognostic-subgroups","display_name":"prognostic subgroups","score":0.49900001287460327},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5590000152587891},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7024668455123901},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6469014286994934},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.5431643128395081},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4296523332595825},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.4294835925102234},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.4279588460922241},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.4270833134651184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3447139859199524},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.33068037033081055},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.32594388723373413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32457756996154785},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.31244683265686035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2088460922241211},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.196.196","doi":"https://doi.org/10.1182/blood.v128.22.196.196","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.196.196","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2606519772","https://openalex.org/W7108474461","https://openalex.org/W2983172312","https://openalex.org/W2906919378","https://openalex.org/W2978086656","https://openalex.org/W2626757935","https://openalex.org/W2551632293","https://openalex.org/W3182873297","https://openalex.org/W4389220528","https://openalex.org/W2591058932"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Segmenting":[2],"multiple":[3,94],"myeloma":[4],"(MM)":[5],"into":[6,136,395],"subgroups":[7],"with":[8,21,53,102,116,175,326,366,384,433,475,490,564,573,590,608,622],"distinct":[9,569],"pathogenesis":[10],"and":[11,25,50,63,77,171,178,204,209,237,254,260,283,302,315,324,332,340,342,347,353,376,407,452,454,469,488,505,509,516,530,557,629,635],"clinical":[12,103,442,592],"behavior":[13],"is":[14,146],"important":[15],"in":[16,23,88,110,119,400,419,587],"order":[17],"to":[18,132,153,161,273,279,292,359,378,389,523,614],"move":[19],"forward":[20],"advancements":[22],"therapy":[24,29],"implement":[26],"a":[27,41,107,128,147,155,183,251,258,422,616],"targeted":[28,200,559],"approach.":[30],"Current":[31],"technologies":[32],"have":[33,40,181,357,578],"elucidated":[34],"five":[35],"major":[36],"translocation":[37,76,392],"groups,":[38,393],"which":[39,189,439],"varying":[42],"effect":[43],"on":[44,250,527,643],"prognosis:":[45],"t(4;14),":[46],"t(6;14),":[47],"t(11;14),":[48],"t(14;16)":[49],"t(14;20)":[51],"along":[52,589],"recurrent":[54,448,465,483,514],"copy":[55,344,466],"number":[56,345,467],"changes":[57,484],"including":[58,414],"deletion":[59],"of":[60,72,93,96,122,173,185,265,402,424,435,457,473,481,492,502,533,536,547,554,562,583,597,602,647,658,751],"CDKN2C":[61],"(1p32.3)":[62],"TP53":[64],"(17p13.1)":[65],"as":[66,68],"well":[67],"gain":[69],"or":[70,649],"amplification":[71],"1q21.":[73],"However,":[74,421],"minor":[75],"mutational":[78,114,574],"groups":[79,383],"are":[80,86,599],"poorly":[81],"described":[82],"because":[83],"sample":[84],"numbers":[85],"limited":[87],"small":[89],"datasets.":[90],"The":[91,140,233,446,611],"availability":[92],"sets":[95],"high":[97,385],"quality":[98,285],"mutation":[99,491,563],"data":[100,115,206,217,249,511,529,586],"associated":[101,572,591,607],"outcomes":[104],"has":[105,567],"provided":[106],"unique":[108],"opportunity":[109],"MM":[111,160,548,588,624],"whereby":[112],"clustering":[113],"chromosomal":[117,334],"aberrations":[118,335],"the":[120,134,221,238,266,293,380,390,415,436,458,471,479,482,531,552,580,627],"context":[121],"gene":[123],"expression":[124,205,374,565,570],"we":[125,312,463,512,541],"can":[126,520,550],"develop":[127,154,162],"molecular":[129,156,558,584],"classification":[130],"system":[131],"segment":[133],"disease":[135,605],"therapeutically":[137],"meaningful":[138,604],"subgroups.":[139],"Multiple":[141,239],"Myeloma":[142,222,234,240],"Genome":[143,196],"Project":[144],"(MGP)":[145],"global":[148,617],"collaborative":[149],"initiative":[150],"that":[151,166,519,549],"aims":[152],"segmentation":[157],"strategy":[158],"for":[159,188,444,660,753],"clinically":[163,544,603],"relevant":[164,545],"tests":[165],"could":[167],"improve":[168],"diagnosis,":[169],"prognosis,":[170],"treatment":[172],"patients":[174,187],"MM.":[176],"Materials":[177],"methods":[179],"We":[180,246,318,356,577],"established":[182,579],"set":[184],"2161":[186],"whole":[190],"exome":[191],"sequencing":[192,202],"(WES;":[193],"n=1436),":[194],"Whole":[195],"Sequencing":[197],"(WGS;":[198],"n=708),":[199],"panel":[201],"(n=993)":[203],"from":[207,220],"RNA-Seq":[208,510],"Gene":[210],"Expression":[211],"arrays":[212],"(n=1497)":[213],"were":[214,218,271,290,336,370,398],"available.":[215],"These":[216],"derived":[219],"XI":[223],"trial":[224],"(UK),":[225],"Intergroupe":[226],"Francophone":[227],"du":[228],"Myeloma/Dana-Faber":[229],"Cancer":[230],"Institute":[231,235],"(MA),":[232],"(AR)":[236],"Research":[241,701,721,758,763],"Foundation":[242],"(IA1":[243],"-":[244],"IA8).":[245],"assembled":[247],"all":[248,288],"secure":[252],"site":[253],"analyzed":[255],"it":[256],"using":[257,263,275,298,306,328,338,350],"streamlined":[259],"consistent":[261,432],"pipeline":[262],"state":[264],"art":[267],"tools.":[268,317],"First,":[269],"BAM":[270],"converted":[272],"FASTQ":[274],"Picard":[276,307,316],"tools":[277,308],"v2.1.1":[278],"extract":[280],"read":[281],"sequences":[282],"base":[284],"scores.":[286],"Next,":[287],"reads":[289],"realigned":[291],"human":[294],"genome":[295],"assembly":[296],"hg19":[297],"BWA-mem.":[299],"Duplicate":[300],"marking":[301],"sorting":[303],"was":[304],"performed":[305],"v2.1.1.":[309],"For":[310],"QAQC":[311],"use":[313],"FASTQC":[314],"identified":[319,337,425,464,513,568],"somatic":[320],"single":[321],"nucleotide":[322],"variants":[323],"indels":[325],"Mutect2":[327],"default":[329],"parameters.":[330],"Translocations":[331],"large":[333,363],"MANTA":[339],"breakdancer":[341],"inferred":[343],"abnormalities":[346,468],"homozygous":[348],"deletions":[349],"Sequenza":[351],"v2.1.2":[352],"ControlFreeC.":[354],"Results":[355],"begun":[358],"integrate":[360],"these":[361,474,496,528,598],"diverse":[362],"genomic":[364],"datasets":[365,632],"various":[367],"correlates.":[368],"Samples":[369],"stratified":[371],"by":[372,404,619],"RNA-seq":[373,406,409],"values":[375],"WES/WGS":[377],"identify":[379],"main":[381,391,447],"cytogenetic":[382],"concordance.":[386],"In":[387,461],"addition":[388,462],"translocations":[394,515],"MAFA,":[396],"t(8;14),":[397],"detected":[399,411],"1.2%":[401],"samples":[403],"both":[405],"WES/WGS.":[408],"also":[410],"fusion":[412,427,517],"transcripts,":[413],"known":[416],"Ig-WHSC1":[417],"transcript":[418],"t(4;14).":[420],"proportion":[423],"in-frame":[426],"genes":[428,493,518,540],"involved":[429],"kinase":[430],"domains":[431],"activation":[434],"Ras/MAPK":[437],"pathway,":[438],"may":[440],"be":[441,521],"targets":[443],"therapy.":[445,525],"mutations":[449],"included":[450],"KRAS":[451],"NRAS,":[453],"negative":[455],"regulators":[456],"NF-\u03baB":[459],"pathway.":[460],"examined":[470],"interaction":[472,480],"mutations.":[476],"This":[477],"highlighted":[478],"at":[485],"1p,":[486],"13q,":[487],"17p":[489],"located":[494],"within":[495],"regions,":[497],"specifically":[498],"indicating":[499],"bi-allelic":[500],"inactivation":[501,535],"CDKN2C,":[503],"RB1":[504],"TP53.":[506],"Using":[507],"WGS":[508],"used":[522],"instruct":[524],"Based":[526],"presence":[532],"homogeneous":[534],"key":[537],"tumor":[538],"expressed":[539],"will":[542],"present":[543],"clusters":[546],"form":[551],"basis":[553],"future":[555],"risk":[556],"trials.":[560],"Interaction":[561],"patterns":[566],"signatures":[571],"groups.":[575],"Conclusions":[576],"largest":[581],"repository":[582],"profiling":[585],"outcome":[593],"data.":[594],"Integrated":[595],"analyses":[596],"enabling":[600],"generation":[601],"segments":[606],"differing":[609],"risk.":[610],"MGP":[612],"intends":[613],"build":[615],"network":[618],"expanding":[620],"collaboration":[621],"leading":[623],"centers":[625],"around":[626],"world":[628],"incorporating":[630],"additional":[631],"through":[633],"current":[634],"new":[636],"collaborations.":[637],"Disclosures":[638],"Mavrommatis:":[639],"Discitis":[640],"DX:":[641],"Membership":[642],"an":[644],"entity's":[645],"Board":[646],"Directors":[648],"advisory":[650],"committees;":[651],"Celgene":[652],"Corporation:":[653],"Employment,":[654,667,675,679,731],"Equity":[655,668,672,676,680,732],"Ownership.":[656,673,677,681,733],"Ashby:University":[657],"Arkansas":[659],"Medical":[661,754],"Sciences:":[662,755],"Employment.":[663,665],"Ortiz:Celgene:":[664],"Towfic:Celgene:":[666],"Ownership;":[669],"Immuneering":[670],"Corp:":[671],"Amatangelo:Celgene:":[674],"Yu:Celgene:":[678],"Avet-Loiseau:celgene:":[682],"Consultancy;":[683,685,687,735,737,739,741,743,745],"janssen:":[684],"sanofi:":[686],"amgen:":[688],"Consultancy.":[689],"Jackson:Janssen:":[690],"Consultancy,":[691,696,706,711,716,726,761,766,770],"Honoraria,":[692,697,707,712,717,727,762],"Speakers":[693,703,708,713,723,728],"Bureau;":[694,704,709,714,724],"Celgene:":[695,740,760],"Other:":[698,718],"Travel":[699,719],"support,":[700,720],"Funding,":[702,722],"MSD:":[705],"Roche:":[710],"Takeda:":[715,765],"Amgen:":[725,736],"Bureau.":[729],"Thakurta:Celgene:":[730],"Munshi:Takeda:":[734],"Janssen:":[738,757],"Merck:":[742],"Pfizer:":[744],"Oncopep:":[746],"Patents":[747],"&":[748],"Royalties.":[749],"Morgan:Univ":[750],"AR":[752],"Employment;":[756],"Funding;":[759,764],"Honoraria;":[767],"Bristol":[768],"Meyers:":[769],"Honoraria.":[771]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-06-30T00:00:00"}